Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Doug Drysdale

Recent news which mentions Doug Drysdale

Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
Tickers CYBN
Tags CYBN Doug Drysdale Markets
From Benzinga
Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals
Tickers CYBN
Tags Benzinga financial results Penny Stocks
From Benzinga
Cybin Stock Down On Laying Off 15% Of Workforce As Part Of A Streamlining Clinical Alignment
Tickers CYBN
Tags CYBN Psychedelics News
From Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
Tickers CYBN DMT
Tags Psychedelics Market News Cybin
From Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
Tickers CYBN MSSTF
Tags Cannabis Market News Cybin
From Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
Tickers CYBN
Tags Doug Drysdale Markets General
From Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
Tickers CYBN DEA MDD
Tags Market News Cybin Cannabis
From Benzinga
Cybin's Psilocybin Analog CYB003 Gets FDA Clearance For Trial To Potentially Treat Major Depressive Disorder
Tickers CYBN
Tags Doug Drysdale Markets Legal
From Benzinga
Cybin Closes Fiscal Year 2022, Reports Financial Results And Major Achievements
Tickers CYBN
Tags Cannabis Market News Benzinga
From Benzinga
Elon Musk Says Psychedelics Should Be Seriously Considered For Therapeutic Uses, Leading Chorus Of Celeb Support
Tickers CYBN TWTR
Tags News CYBN Jim Cramer
From Benzinga
Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin
Tickers CYBE CYBN ENTBF
Tags Eurozone Doug Drysdale Markets
From Benzinga
Major Depressive Disorder Could Soon Have Treatment Option Via Cybin's Psilocybin Analog
Tickers CYBN
Tags Doug Drysdale Markets Topics
From Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
Tickers CYBN
Tags Markets Doug Drysdale News
From Benzinga
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
Tickers CYBN DMT PCC
Tags Psychedelics PCC Psilocybin
From Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
Tickers AGN CYBN PTX
Tags Psychedelics Benzinga Psychedelics Capital Conference Small Business
From Benzinga
Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event
Tickers CYBN FTRP MMDCF PSYC
Tags Markets Robert Barrow PSYC
From Benzinga
Cybin Obtains U.S. Patent For Is Proprietary Compound Deuterated DMT Aimed At Treating Anxiety Disorders
Tickers CYBN
Tags CYBN News Benzinga
From Benzinga
Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana
Tickers CYBN FTRP WSNAF
Tags Penny Stocks WSNAF Benzinga
From Benzinga
Why Cybin Shares Are Rising
Tickers CYBN
Tags Market News Benzinga Doug Drysdale
From Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
Tickers CYBN
Tags Cybin Market News Doug Drysdale
From Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
Tickers CYBN
Tags Small Cap Biotech Psychedelics Therapy
From Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
Tickers CMPS CYBN FLHLF NMLSF
Tags CMPS CYBN psychedelics
From Benzinga
Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know
Tickers CLXPF CMPS GBNH
Tags GBNH Small Cap CMPS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.